Literature DB >> 20418756

Phenotype and genotype of pancreatic cancer cell lines.

Emily L Deer1, Jessica González-Hernández, Jill D Coursen, Jill E Shea, Josephat Ngatia, Courtney L Scaife, Matthew A Firpo, Sean J Mulvihill.   

Abstract

The dismal prognosis of pancreatic adenocarcinoma is due in part to a lack of molecular information regarding disease development. Established cell lines remain a useful tool for investigating these molecular events. Here we present a review of available information on commonly used pancreatic adenocarcinoma cell lines as a resource to help investigators select the cell lines most appropriate for their particular research needs. Information on clinical history; in vitro and in vivo growth characteristics; phenotypic characteristics, such as adhesion, invasion, migration, and tumorigenesis; and genotypic status of commonly altered genes (KRAS, p53, p16, and SMAD4) was evaluated. Identification of both consensus and discrepant information in the literature suggests careful evaluation before selection of cell lines and attention be given to cell line authentication.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20418756      PMCID: PMC2860631          DOI: 10.1097/MPA.0b013e3181c15963

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  128 in total

1.  Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines.

Authors:  A Menke; C Philippi; R Vogelmann; B Seidel; M P Lutz; G Adler; D Wedlich
Journal:  Cancer Res       Date:  2001-04-15       Impact factor: 12.701

2.  Pancreatic cancer cells invasiveness is mainly affected by interleukin-1beta not by transforming growth factor-beta1.

Authors:  E Greco; D Basso; P Fogar; S Mazza; F Navaglia; C F Zambon; A Falda; S Pedrazzoli; E Ancona; M Plebani
Journal:  Int J Biol Markers       Date:  2005 Oct-Dec       Impact factor: 2.659

3.  Multi-scale modeling of a wound-healing cell migration assay.

Authors:  Anna Q Cai; Kerry A Landman; Barry D Hughes
Journal:  J Theor Biol       Date:  2006-10-28       Impact factor: 2.691

4.  Gene expression profile of metastatic human pancreatic cancer cells depends on the organ microenvironment.

Authors:  Toru Nakamura; Isaiah J Fidler; Kevin R Coombes
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

5.  Pancreatic cancer cell-derived vascular endothelial growth factor is biologically active in vitro and enhances tumorigenicity in vivo.

Authors:  J Luo; P Guo; K Matsuda; N Truong; A Lee; C Chun; S Y Cheng; M Korc
Journal:  Int J Cancer       Date:  2001-05-01       Impact factor: 7.396

6.  Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas.

Authors:  M Schutte; R H Hruban; J Geradts; R Maynard; W Hilgers; S K Rabindran; C A Moskaluk; S A Hahn; I Schwarte-Waldhoff; W Schmiegel; S B Baylin; S E Kern; J G Herman
Journal:  Cancer Res       Date:  1997-08-01       Impact factor: 12.701

7.  Tissue plasminogen activator is required for the growth, invasion, and angiogenesis of pancreatic tumor cells.

Authors:  Víctor M Díaz; Jesús Planaguma; Timothy M Thomson; Jaume Reventós; Rosanna Paciucci
Journal:  Gastroenterology       Date:  2002-03       Impact factor: 22.682

8.  Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenografts.

Authors:  Chandrajit P Raut; Steffan Nawrocki; Laura M Lashinger; Darren W Davis; Sanaz Khanbolooki; Henry Xiong; Lee M Ellis; David J McConkey
Journal:  Cancer Biol Ther       Date:  2004-12-09       Impact factor: 4.742

9.  Interleukin-8 as a macrophage-derived mediator of angiogenesis.

Authors:  A E Koch; P J Polverini; S L Kunkel; L A Harlow; L A DiPietro; V M Elner; S G Elner; R M Strieter
Journal:  Science       Date:  1992-12-11       Impact factor: 47.728

10.  Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression.

Authors:  J Itakura; T Ishiwata; H Friess; H Fujii; Y Matsumoto; M W Büchler; M Korc
Journal:  Clin Cancer Res       Date:  1997-08       Impact factor: 12.531

View more
  382 in total

1.  Targeted silencing of TRPM7 ion channel induces replicative senescence and produces enhanced cytotoxicity with gemcitabine in pancreatic adenocarcinoma.

Authors:  Nelson S Yee; Weiqiang Zhou; Minsun Lee; Rosemary K Yee
Journal:  Cancer Lett       Date:  2011-12-11       Impact factor: 8.679

Review 2.  Targeting tight junctions during epithelial to mesenchymal transition in human pancreatic cancer.

Authors:  Daisuke Kyuno; Hiroshi Yamaguchi; Tatsuya Ito; Tsuyoshi Kono; Yasutoshi Kimura; Masafumi Imamura; Takumi Konno; Koichi Hirata; Norimasa Sawada; Takashi Kojima
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

3.  Lysophosphatidic acid induces both EGFR-dependent and EGFR-independent effects on DNA synthesis and migration in pancreatic and colorectal carcinoma cells.

Authors:  Ingun Heiene Tveteraas; Monica Aasrum; Ingvild Johnsen Brusevold; John Ødegård; Thoralf Christoffersen; Dagny Sandnes
Journal:  Tumour Biol       Date:  2015-09-19

4.  Epithelial mesenchymal transition and pancreatic tumor initiating CD44+/EpCAM+ cells are inhibited by γ-secretase inhibitor IX.

Authors:  Vindhya Palagani; Mona El Khatib; Uta Kossatz; Przemyslaw Bozko; Martin R Müller; Michael P Manns; Till Krech; Nisar P Malek; Ruben R Plentz
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

5.  Machine learning improves classification of preclinical models of pancreatic cancer with chemical exchange saturation transfer MRI.

Authors:  Joshua M Goldenberg; Julio Cárdenas-Rodríguez; Mark D Pagel
Journal:  Magn Reson Med       Date:  2018-09-17       Impact factor: 4.668

6.  Two-dimensional culture of human pancreatic adenocarcinoma cells results in an irreversible transition from epithelial to mesenchymal phenotype.

Authors:  Ya'an Kang; Ran Zhang; Rei Suzuki; Shao-qiang Li; David Roife; Mark J Truty; Deyali Chatterjee; Ryan M Thomas; James Cardwell; Yu Wang; Huamin Wang; Matthew H Katz; Jason B Fleming
Journal:  Lab Invest       Date:  2014-12-08       Impact factor: 5.662

7.  In vitro study of the cytotoxicity of thymoquinone/curcumin fluorescent liposomes.

Authors:  Heba Mohamed Fahmy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-08-03       Impact factor: 3.000

8.  Loss of Trefoil Factor 2 From Pancreatic Duct Glands Promotes Formation of Intraductal Papillary Mucinous Neoplasms in Mice.

Authors:  Junpei Yamaguchi; Mari Mino-Kenudson; Andrew S Liss; Sanjib Chowdhury; Timothy C Wang; Carlos Fernández-Del Castillo; Keith D Lillemoe; Andrew L Warshaw; Sarah P Thayer
Journal:  Gastroenterology       Date:  2016-08-12       Impact factor: 22.682

9.  Molecular Imaging of the Tumor Microenvironment Reveals the Relationship between Tumor Oxygenation, Glucose Uptake, and Glycolysis in Pancreatic Ductal Adenocarcinoma.

Authors:  Kazutoshi Yamamoto; Jeffrey R Brender; Tomohiro Seki; Shun Kishimoto; Nobu Oshima; Rajani Choudhuri; Stephen S Adler; Elaine M Jagoda; Keita Saito; Nallathamby Devasahayam; Peter L Choyke; James B Mitchell; Murali C Krishna
Journal:  Cancer Res       Date:  2020-04-03       Impact factor: 12.701

10.  Integrated in silico and 3D in vitro model of macrophage migration in response to physical and chemical factors in the tumor microenvironment.

Authors:  Sharon Wei Ling Lee; R J Seager; Felix Litvak; Fabian Spill; Je Lin Sieow; Penny Hweixian Leong; Dillip Kumar; Alrina Shin Min Tan; Siew Cheng Wong; Giulia Adriani; Muhammad Hamid Zaman; And Roger D Kamm
Journal:  Integr Biol (Camb)       Date:  2020-04-20       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.